![]() |
Volumn 39, Issue 5, 2001, Pages 558-564
|
Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction
|
Author keywords
Apomorphine SL; Crossover study; Dopamine agonist; Erectile dysfunction; Risk benefit ratio
|
Indexed keywords
APOMORPHINE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
ERECTILE DYSFUNCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
SEXUAL INTERCOURSE;
ADMINISTRATION, SUBLINGUAL;
ADULT;
AGED;
APOMORPHINE;
COITUS;
CROSS-OVER STUDIES;
DOPAMINE AGONISTS;
DOUBLE-BLIND METHOD;
HUMANS;
IMPOTENCE;
MALE;
MIDDLE AGED;
|
EID: 0034916235
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000052503 Document Type: Article |
Times cited : (139)
|
References (15)
|